Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 15

1.

Clinical and Ultrasound Characteristics of the Microcystic Elongated and Fragmented (MELF) Pattern in Endometrial Cancer According to the International Endometrial Tumor Analysis (IETA) criteria.

Eriksson LSE, Nastic D, Frühauf F, Fischerova D, Nemejcova K, Bono F, Franchi D, Fruscio R, Ghioni M, Haak LA, Hejda V, Meskauskas R, Opolskiene G, Pascual MA, Testa A, Tresserra F, Zannoni GF, Carlson JW, Epstein E.

Int J Gynecol Cancer. 2019 Jan;29(1):119-125. doi: 10.1136/ijgc-2018-000045.

PMID:
30640693
2.

Bimodality of intratumor Ki67 expression is an independent prognostic factor of overall survival in patients with invasive breast carcinoma.

Laurinavicius A, Plancoulaine B, Rasmusson A, Besusparis J, Augulis R, Meskauskas R, Herlin P, Laurinaviciene A, Abdelhadi Muftah AA, Miligy I, Aleskandarany M, Rakha EA, Green AR, Ellis IO.

Virchows Arch. 2016 Apr;468(4):493-502. doi: 10.1007/s00428-016-1907-z. Epub 2016 Jan 27.

PMID:
26818835
3.

Common bile duct villous adenoma: a case report and review of the literature.

Čekas K, Rudaitis V, Beiša V, Jotautas V, Rutkauskaitė D, Meškauskas R, Stratilatovas E.

J Med Case Rep. 2016 Jan 21;10:18. doi: 10.1186/s13256-015-0789-z.

4.

Primary cardiac lymphoma: two cases and a review of literature.

Jonavicius K, Salcius K, Meskauskas R, Valeviciene N, Tarutis V, Sirvydis V.

J Cardiothorac Surg. 2015 Oct 30;10:138. doi: 10.1186/s13019-015-0348-0. Review.

5.

Ki67/SATB1 ratio is an independent prognostic factor of overall survival in patients with early hormone receptor-positive invasive ductal breast carcinoma.

Laurinavicius A, Green AR, Laurinaviciene A, Smailyte G, Ostapenko V, Meskauskas R, Ellis IO.

Oncotarget. 2015 Dec 1;6(38):41134-45. doi: 10.18632/oncotarget.5838.

6.

A methodology for comprehensive breast cancer Ki67 labeling index with intra-tumor heterogeneity appraisal based on hexagonal tiling of digital image analysis data.

Plancoulaine B, Laurinaviciene A, Herlin P, Besusparis J, Meskauskas R, Baltrusaityte I, Iqbal Y, Laurinavicius A.

Virchows Arch. 2015 Oct 19. [Epub ahead of print]

PMID:
26481244
7.

Frame shift mutations of the ZMPSTE24 gene in two siblings with restrictive dermopathy.

Matulevičienė A, Meškienė R, Morkūnienė A, Ambrozaitytė L, Meškauskas R, Garunkštienė R, Drazdienė N, Utkus A, Kučinskas V.

Clin Dysmorphol. 2016 Jan;25(1):7-11. doi: 10.1097/MCD.0000000000000100.

PMID:
26379196
8.

Digital immunohistochemistry wizard: image analysis-assisted stereology tool to produce reference data set for calibration and quality control.

Plancoulaine B, Laurinaviciene A, Meskauskas R, Baltrusaityte I, Besusparis J, Herlin P, Laurinavicius A.

Diagn Pathol. 2014;9 Suppl 1:S8. doi: 10.1186/1746-1596-9-S1-S8. Epub 2014 Dec 19.

9.

Digital immunohistochemistry platform for the staining variation monitoring based on integration of image and statistical analyses with laboratory information system.

Laurinaviciene A, Plancoulaine B, Baltrusaityte I, Meskauskas R, Besusparis J, Lesciute-Krilaviciene D, Raudeliunas D, Iqbal Y, Herlin P, Laurinavicius A.

Diagn Pathol. 2014;9 Suppl 1:S10. doi: 10.1186/1746-1596-9-S1-S10. Epub 2014 Dec 19.

10.

Rare types of breast carcinoma.

Gudaviciene D, Steponaviciene L, Meskauskas R, Smailyte G, Aleknavicius E.

Open Med (Wars). 2014 Nov 24;10(1):92-96. doi: 10.1515/med-2015-0016. eCollection 2015.

11.

A methodology to ensure and improve accuracy of Ki67 labelling index estimation by automated digital image analysis in breast cancer tissue.

Laurinavicius A, Plancoulaine B, Laurinaviciene A, Herlin P, Meskauskas R, Baltrusaityte I, Besusparis J, Dasevicius D, Elie N, Iqbal Y, Bor C.

Breast Cancer Res. 2014;16(2):R35.

12.

Genotypes and phenotypes of 162 families with a glomulin mutation.

Brouillard P, Boon LM, Revencu N, Berg J, Dompmartin A, Dubois J, Garzon M, Holden S, Kangesu L, Labrèze C, Lynch SA, McKeown C, Meskauskas R, Quere I, Syed S, Vabres P, Wassef M, Mulliken JB, Vikkula M; GVM Study Group.

Mol Syndromol. 2013 Apr;4(4):157-64. doi: 10.1159/000348675. Epub 2013 Mar 26.

13.

Triple negative breast cancer: adjuvant chemotherapy effect on survival.

Steponaviciene L, Lachej-Mikeroviene N, Smailyte G, Aleknavicius E, Meskauskas R, Didziapetriene J.

Adv Med Sci. 2011;56(2):285-90. doi: 10.2478/v10039-011-0047-6.

PMID:
22112429
14.

The contribution of founder mutations in BRCA1 to breast and ovarian cancer in Lithuania.

Elsakov P, Kurtinaitis J, Petraitis S, Ostapenko V, Razumas M, Razumas T, Meskauskas R, Petrulis K, Luksite A, Lubiński J, Górski B, Narod SA, Gronwald J.

Clin Genet. 2010 Oct;78(4):373-6. doi: 10.1111/j.1399-0004.2010.01404.x.

PMID:
20345474
15.

[Mamography and core biopsy value in diagnosis of nonpalpable breast tumors].

Ostapenko V, Mikalauskas T, Bruzas S, Mudenas A, Sabonis J, Tutkus J, Meskauskas R, Miliauskas P, Jackevicius A, Grinyte L.

Medicina (Kaunas). 2004;40(12):1165-9. Lithuanian.

Supplemental Content

Loading ...
Support Center